Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-20

Clinical Trial Update: Comprehensive Versus Primary Tumor Radiotherapy in Oligometastatic Prostate Cancer [NA]

View source ↗

Summary

The trial compares comprehensive radiotherapy to primary-tumor radiotherapy for oligometastatic prostate cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Peking University First Hospital | Conditions: Prostate Cancer, Oligometastatic Prostate Cancer | NA | Status: RECRUITING